Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : NVO source : Www.prnewswire.com save search
Peptide Therapeutics Market Projected to Reach $57.97 billion by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-19 (Crawled : 15:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 0.24%
H: 0.42%
C: 0.42%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.84%
H: 0.86%
C: -0.62%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.58%
H: 0.99%
C: 0.97%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.21%
H: 0.11%
C: -3.05%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -0.18%
H: 0.84%
C: 0.6%
report reach therapeutics market
REDUCED secures EUR 6 million financing led by Novo Holdings to scale its natural food ingredients business
Published: 2024-04-04 (Crawled : 06:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.1%
H: 0.46%
C: -2.32%
business natural million food
2023 Novo Holdings Asia Investments Annual Review/Business Update
Published: 2024-04-03 (Crawled : 07:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.75%
H: 0.0%
C: 0.0%
investments update asia
2023 Novo Holdings Bioindustrial Investments Team Annual Review/Business Update
Published: 2024-03-15 (Crawled : 09:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.52%
H: 0.09%
C: -1.13%
investments update
Novo Holdings Portfolio Company Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca
Published: 2024-03-14 (Crawled : 08:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.77%
H: 0.05%
C: -0.93%
pharma company astrazeneca acquired agreement
Global Antidiabetics Market 10 Year Forecast Report 2024-2034, by Product Type, by Application, by Distribution Channel and Region
Published: 2024-03-13 (Crawled : 18:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.64%
H: 0.94%
C: -0.56%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.27%
H: 0.5%
C: 0.11%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
report distribution year global market
Novo Holdings reports Total Income and Investment Returns of DKK 31 billion (€4.2 billion) for 2023. Total Assets grow by 38% to DKK 1,114 billion (€149 billion)
Published: 2024-03-12 (Crawled : 07:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.27%
H: 2.67%
C: 2.67%
total
FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or Overweight
Published: 2024-03-08 (Crawled : 20:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
| Email alert
Add to watchlist
fda obesity first treatment risk heart
Insulin Pen Global Market Outlook Report 2024-2028: Current Market Size and Revenue Growth Prospects for Insulin Pens, with Market Share Analysis by Type, Onset Time, End User and Geographical Region
Published: 2024-02-23 (Crawled : 17:00) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.37%
H: 0.58%
C: 0.58%
VTRS A | $11.25 1.17% 1.16% 4.7M
|
Health Technology
|
| O: 0.0%
H: 1.93%
C: 1.27%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.68%
H: 0.4%
C: -0.18%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.89%
H: 0.4%
C: 0.17%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.97%
H: 0.0%
C: 0.0%
report revenue global insulin growth market
Novo Holdings invests in Manipal Hospitals, a leading private hospital chain in India
Published: 2024-02-06 (Crawled : 08:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.06%
H: 0.31%
C: -0.61%
hospital india
Transthyretin Amyloidosis Market is Predicted to Exhibit Remarkable Growth by 2032, Predicts DelveInsight | Key Players - Attralus, Alnylam Pharmaceuticals, Ionis Pharmaceuticals, AstraZeneca, Alexion Pharmaceuticals, Novo Nordisk
Published: 2024-01-24 (Crawled : 23:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.49%
H: 0.0%
C: -0.05%
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: 0.38%
H: 2.34%
C: 1.56%
key growth market
Elo Life Systems Announces Oversubscribed $20.5 Million Series A2 Funding Round
Published: 2024-01-24 (Crawled : 14:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.21%
H: 0.36%
C: -1.35%
life million series funding
Beta-thalassemia Market to Witness Upsurge in Growth During the Study Period (2019-2032), Evaluates DelveInsight | Leading Companies - Vertex Pharmaceuticals, CRISPR Therapeutics, Agios Pharmaceuticals, Celgene, Forma Therapeutics
Published: 2024-01-17 (Crawled : 22:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.36%
H: 1.32%
C: 1.18%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.21%
H: 0.0%
C: 0.0%
VRTX | News | $394.43 0.24% 0.24% 1.3M
|
Health Technology
|
| O: -0.5%
H: 0.76%
C: 0.32%
EDIT | $5.5 -0.9% -0.91% 2.3M
|
Health Technology
|
| O: 0.83%
H: 0.35%
C: -3.66%
AGIO | $29.52 0.31% 0.3% 750K
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: -2.2%
crispr companies therapeutics growth study market
Focal Segmental Glomerulosclerosis Market to Observe Impressive Growth by 2032, Predicts DelveInsight | Leading Companies - ACELYRIN, Genentech, ChemoCentryx, Travere Therapeutics, Boehringer Ingelheim, Chinook Therapeutics
Published: 2024-01-10 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.1%
H: 0.0%
C: 0.0%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.33%
H: 0.35%
C: -1.5%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.67%
H: 0.85%
C: 0.21%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: 0.0%
ALDX | $3.865 -2.89% -2.98% 430K
|
Health Technology
|
| O: -1.8%
H: 0.46%
C: -2.44%
companies therapeutics growth market
Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs
Published: 2024-01-08 (Crawled : 13:30) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 2.71%
H: 0.36%
C: 0.11%
LEXX | $2.27 0.89% 0.88% 62K
|
Health Technology
|
| O: 0.0%
H: 8.15%
C: 1.48%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: -0.37%
H: 1.09%
C: 0.75%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 0.19%
H: 0.34%
C: 0.21%
MRK | News | $125.78 0.44% 0.0% 8.4M
|
Health Technology
|
| O: 0.32%
H: 0.26%
C: -0.18%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.28%
H: 0.99%
C: 0.93%
2023 Novo Holdings Seed Investments Team Annual Review/Business Update
Published: 2024-01-04 (Crawled : 08:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: 1.44%
H: 3.68%
C: 2.4%
investments update
Biologics Global Market Forecast Report 2024-2034 - Challenges Posed by Patent Expiration for Biologics
Published: 2023-12-22 (Crawled : 17:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 3.66%
H: 0.0%
C: -0.12%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 3.33%
H: 0.0%
C: -2.93%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.31%
H: 0.39%
C: -0.44%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 1.09%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.18%
H: 0.5%
C: -0.46%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: -0.78%
H: 5.15%
C: 2.81%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.58%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.03%
H: 0.0%
C: 0.0%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: 0.52%
H: 0.58%
C: 0.05%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.34%
H: 1.02%
C: 0.59%
BIIB | $194.39 2.03% 1.99% 1.6M
|
Health Technology
|
| O: 0.57%
H: 1.36%
C: 1.04%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 1.06%
H: 0.18%
C: -1.06%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.24%
H: 2.03%
C: 1.49%
patent report global market
Incretin-based Drugs Market to Reach $73.9 billion, globally, by 2032 at 7.9% CAGR: Allied Market Research
Published: 2023-12-15 (Crawled : 15:30) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -3.0%
H: 2.15%
C: 2.15%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.48%
H: 0.0%
C: -0.44%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -1.31%
H: 0.56%
C: -0.17%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -4.44%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.93%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -2.23%
H: 0.28%
C: -0.11%
reach research market
Liberty All-Star Equity Fund November 2023 Monthly Update
Published: 2023-12-13 (Crawled : 18:00) - prnewswire.com
SNEJF | News | $82.28 2.78% 1.1K
|
Consumer Durables
|
| O: -0.26%
H: 3.39%
C: 3.39%
SKX 4 | $56.41 -0.79% 0.0% 5M
|
Consumer Non-Durables
|
| O: 1.19%
H: 1.61%
C: 0.58%
NOW | $713.91 -2.39% -0.13% 1.5M
|
Technology Services
|
| O: -0.79%
H: 0.3%
C: -4.17%
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.38%
H: 0.21%
C: -0.53%
IQV | $228.09 0.41% 0.0% 760K
|
Health Services
|
| O: 0.35%
H: 3.61%
C: 1.68%
SWKS 4 | $96.09 -1.57% -1.59% 2.6M
|
Electronic Technology
|
| O: 0.94%
H: 3.45%
C: 3.11%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: -0.26%
H: 0.56%
C: 0.25%
PYPL A | $62.31 0.34% 0.34% 12M
|
Technology Services
|
| O: 1.96%
H: 1.89%
C: -1.7%
ADSK | $216.6 2.83% 2.76% 3.1M
|
Technology Services
|
| O: 0.19%
H: 3.09%
C: 2.32%
AMZN | $174.63 -2.56% -2.63% 54M
|
Retail Trade
|
| O: 0.73%
H: 0.41%
C: -1.67%
update liberty
Hoba Therapeutics raises EUR 23 million in a Series A to advance new drug candidate against chronic neuropathic pain
Published: 2023-12-11 (Crawled : 07:00) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M
|
Health Technology
|
| O: -0.22%
H: 0.68%
C: 0.23%
drug candidate series therapeutics
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.